Diagnosis and man- agement of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39:4208 4218. doi: 10.1093/eurheartj/ehx003 607. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK. Prospective study of markers of hemostatic func- tion with risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1999;100:736 742. doi: 608. Zakai NA, Judd SE, Kissela B, Howard G, Safford MM, Cushman M. Factor VIII, protein C and cardiovascular disease risk: the REasons for Geographic and Racial Differences in Stroke Study (REGARDS). Thromb Haemost. 609. Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic ap- proach to laboratory testing and update on monitoring of direct oral antico- agulants. Blood Res. 2014;49:85 94. doi: 10.5045/br.2014.49.2.85 610. Gouse BM, Boehme AK, Monlezun DJ, Siegler JE, George AJ, Brag K, Albright KC, Beasley TM, Leissinger C, El Khoury R, et al. New thrombotic events in ischemic stroke patients with elevated factor VIII. Thrombosis. 611. Raffield LM, Lu AT, Szeto MD, Little A, Grinde KE, Shaw J, Auer PL, Cushman M, Horvath S, Irvin MR, et al; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Hematology & Hemostasis Working Group. Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analy- sis in African Americans. J Thromb Haemost. 2020;18:1335 1347. doi: 612. Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, et al; APASS Investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004;291:576 584. doi: 613. 